|
2024
|
Invention
|
Salt form and crystal form of plk1 kinase inhibitor, and preparation method therefor and use ther... |
|
|
Invention
|
Salt form and crystal form of thienopyrimidine compound, and preparation method therefor and use ... |
|
|
Invention
|
Nk-3 receptor antagonist compound, pharmaceutical composition, preparation method therefore and u... |
|
|
Invention
|
Preparation method of 2,6-dioxaspiro [4,5] decane derivatives and salts thereof.
The present dis... |
|
2023
|
Invention
|
Cdk2 inhibitor, preparation method therefor, and use thereof. A CDK2 inhibitor and a preparation ... |
|
|
P/S
|
Medicines for human purposes. |
|
|
Invention
|
Heterocyclic compound as taar1 ligand agonist. Provided are a heterocyclic compound used as a TAA... |
|
|
Invention
|
19-nor-c3,3-disubstituted c21-azacyclo-substituted steroid and method for using same. AAR positiv... |
|
2022
|
Invention
|
Protein kinase inhibitor, preparation method therefor, and application thereof. A series of compo... |
|
|
Invention
|
Gonadotropin-releasing hormone antagonist, and preparation method therefor and use thereof. The p... |
|
|
Invention
|
Prodrug of cannabidiol, and pharmaceutical composition and use thereof. A prodrug of cannabidiol,... |
|
2021
|
Invention
|
2a receptor inhibitor or inverse agonist, preparation method therefor, and application thereof. 2... |
|
2020
|
Invention
|
Compound and preparation method therefor and use thereof. Provided are a new impurity compound of... |
|
|
Invention
|
Vmat2 inhibitor and preparation method therefor and application thereof. The present invention re... |
|
2019
|
Invention
|
Pyrazolopyrimidine derivative as selective trk inhibitor.
The present invention discloses a comp... |
|
|
P/S
|
Diagnostic apparatus for medical purposes; medical apparatus
and instruments; analytical apparat... |
|
|
P/S
|
Medicines for human purposes; nutraceutical preparations for
therapeutic or medical purposes; ph... |
|
|
P/S
|
Diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells and DNA; m... |
|
|
P/S
|
Medicinal preparations for the treatment of infectious diseases and for use in oncology; nutraceu... |
|
|
P/S
|
Retail store services for pharmaceutical, veterinary and sanitary preparations and medical suppli... |
|
|
P/S
|
Physical therapy; nursing, medical; pharmacy advice; therapy
services; medical clinic services; ... |
|
|
P/S
|
Medicines for human purposes; Chemical preparations for pharmaceutical purposes. |
|
|
P/S
|
Medicinal preparations for the treatment of major depressive disorder (MDD) |
|
|
Invention
|
Composition comprising oxadiazole derivative, preparation method therefor and use thereof. Disclo... |
|
|
P/S
|
Medicines for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, c... |
|
2018
|
Invention
|
Dosage regimen of paliperidone palmitate extended-release injectable suspension. Provided herein ... |
|
|
P/S
|
Medicines for human purposes; medicines for veterinary
purposes; wadding for medical purposes; g... |
|
|
P/S
|
Medical preparations for the treatment of psychological and mental disorders, depression, schizop... |
|
|
Invention
|
Crystal form of oxadiazole derivative as ido1 inhibitor and preparation method therefor. Disclose... |
|
|
Invention
|
Method for preparing 1,2,5-oxadiazole compound, and intermediate thereof. Disclosed are a pharmac... |
|
|
Invention
|
Crystal form of ido1 inhibitor and preparation method therefor. Disclosed are a crystal form of a... |
|
2017
|
Invention
|
Exenatide-containing composition and preparation method thereof.
An exenatide-containing composi... |
|
|
Invention
|
Pharmaceutical compositions of goserelin sustained release microspheres. A composition of goserel... |
|
|
P/S
|
Pharmaceutical preparations; API (active pharmaceutical
ingredient). |
|
|
Invention
|
Ido1 inhibitor and preparation method and application thereof.
A compound as an indoleamine-2,3-... |
|
|
Invention
|
Ido1 inhibitor and preparation method and application thereof. A compound as an indoleamine-2,3-d... |
|
2016
|
P/S
|
Medical apparatus and instruments. Hospitals; Beauty salons. |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations;
drugs for medical purposes. |
|
|
P/S
|
Medicines for human purposes; pharmaceutical preparations;
dietetic substances adapted for medic... |
|
|
P/S
|
Medicines for human purposes; drugs for medical purposes;
capsules for medicines; tonics [medici... |
|
|
P/S
|
Pharmaceutical preparations; medicines for human purposes. |
|
|
P/S
|
Medicinal preparations for treatment of psychiatric and mental disorders, schizophrenia and bipol... |
|
|
Invention
|
Rotigotine behenate, and manufacturing method and application thereof. The present invention rela... |
|
|
Invention
|
Rotigotine behenate, preparation method and use thereof. The present invention relates to a rotig... |
|
2015
|
Invention
|
Pharmaceutical compositions of goserelin sustained release microspheres.
A composition of gosere... |
|
|
Invention
|
Exenatide-containing composition and preparation method therefor.
An exenatide-containing compos... |
|
|
Invention
|
Exenatide-containing composition and preparation method therefor. An exenatide-containing composi... |
|
2014
|
Invention
|
Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochlori... |
|
|
Invention
|
Goserelin sustained release microsphere pharmaceutical composition. A long acting goserelin susta... |
|
2013
|
Invention
|
Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methyl-benzoate hydrochlor... |
|
2012
|
Invention
|
Pharmaceutical compositions of triptorelin microspheres.
Sustained release triptorelin microsphe... |
|
|
Invention
|
Pharmaceutical compositions of triptorelin microspheres. A sustained release triptorelin microsph... |
|
|
Invention
|
5,6,7,8-tetrahydro-6-[n,n-bis[(2-thienyl)ethyl]]amino-1-naphthol, and preparing method and use th... |
|
|
Invention
|
Method for industrially preparing nitrogen substituted amino-5,6,7,8-tetrahydronaphthol. A method... |
|
|
Invention
|
Risperidone sustained release microsphere composition. A risperidone sustained release microspher... |
|
|
Invention
|
Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of d... |
|
2011
|
Invention
|
Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigoti... |
|
2009
|
P/S
|
Medicines for human purposes; medicinal drinks;
pharmaceutical preparations; chemico-pharmaceuti... |
|
2007
|
P/S
|
Pharmaceutical preparations and substances. |
|
2006
|
Invention
|
Compounds, preparation process, and uses thereof used for interrupting reuptake of 5-hydroxytrypt... |
|
2005
|
Invention
|
Long acting sustained-release formulation containing dopamine receptor agonist and the preparatio... |
|
|
Invention
|
Smectite dispersible tablets and the preparation thereof. A smectite dispersible tablet and the p... |
|
|
Invention
|
The dispersible montmorillonite tablet and its preparation technology. A dispersible montmorillon... |
|
2004
|
Invention
|
Injectable sustained-release microspheres of huperzine a compoounds. Sustained-release microspher... |
|
2002
|
Invention
|
Injectable sustained-release microspheres of huperzine a compounds. The present invention relates... |
